| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Verrica Pharmaceuticals Inc. (VRCA) has 9 insiders with recent SEC Form 4 filings, including 2 buys and 0 sells. VRCA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 3.35M | $26.75M | - | |
| CEO | 182.6K | $1.46M | - | |
| COO | 21.0K | $167.8K | - | |
| Dir | 20.0K | $159.8K | - | |
| Dir | 20.0K | $159.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 19, 2018 | Manning Paul B53 | Director, 10% Owner | Buy | 300,000 | $15.00 | $4,500,000.00 | +3.4% |